Evaluation of human herpesvirus‐8 viremia and antibody positivity in patients with HIV infection with human herpesvirus‐8‐related diseases
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Dai Watanabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: AIDS Medical Center, NHO Osaka National Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, HIV Infections, Sarcoma, Kaposi, HIV Seropositivity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Human herpesvirus‐8 (HHV‐8) viremia is associated with refractory conditions in patients infected with HIV‐1. Therefore, we evaluated the factors related to plasma HHV‐8‐DNA. Participants included patients infected with HIV‐1 who visited our hospital. Plasma HHV‐8‐DNA levels were measured using real‐time polymerase chain reaction, and anti‐HHV‐8 antibodies were assessed through enzyme immunoassays using multiple antigens (K8.1, ORF59, ORF65, and LANA). Factors related to plasma HHV‐8‐DNA were examined using Fisher's exact test or Mann–Whitney U test. The study involved 36 patients infected with HIV‐1, of whom 19 were histologically diagnosed with Kaposi's sarcoma (KS), two had multicentric Castleman's disease (MCD), and 15 did not exhibit HHV‐8‐related disease. Before the introduction of antiretroviral therapy (ART), plasma HHV‐8‐DNA was detected in 44% (7/16) of patients with KS and in 9% (1/11) of patients without HHV‐8‐related disease. Among patients with KS, elevated plasma HHV‐8‐DNA levels (≥0.05 copies/µL) correlated with the presence of CDC category C diseases other than KS ( p = 0.0337), anti‐HHV‐8 antibody negativity ( p = 0.0337), anemia ( p = 0.0474), and thrombocytopenia ( p = 0.0146). Following ART initiation, the percentage of patients positive for plasma HHV‐8‐DNA decreased from 44% (7/16) to 6% (1/17), and the percentage of patients positive for anti‐HHV‐8 antibodies increased from 44% (7/16) to 88% (15/17). Finally, plasma HHV‐8‐DNA positivity and anti‐HHV‐8 antibody negativity were observed in two patients with MCD. Our findings suggest that insufficient production of anti‐HHV‐8 antibodies was associated with HHV‐8 viremia, and that anti‐HHV‐8 antibody production was recovered with ART; thus, indicating the possibility of involvement of humoral immunity in suppressing HHV‐8 viremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AIDS Medical Center, NHO Osaka National Hospital, Osaka, Japan.
- Department of Advanced Medicine for HIV Infection, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
ORCID-Profile: Dai Watanabe, Shun Iida, Harutaka Katano
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Watanabe, D., Iida, S., Hirota, K., Ueji, T., Matsumura, T., Nishida, Y., Uehira, T., Katano, H., & Shirasaka, T. (2023). Evaluation of human herpesvirus‐8 viremia and antibody positivity in patients with HIV infection with human herpesvirus‐8‐related diseases. Journal of Medical Virology. https://doi.org/10.1002/jmv.29324
Vancouver
Watanabe D, Iida S, Hirota K, Ueji T, Matsumura T, Nishida Y, et al. Evaluation of human herpesvirus‐8 viremia and antibody positivity in patients with HIV infection with human herpesvirus‐8‐related diseases. Journal of Medical Virology. 2023. doi:10.1002/jmv.29324
BibTeX
@article{Watanabe2023,
author = {Watanabe, Dai and Iida, Shun and Hirota, Kazuyuki and Ueji, Takashi and Matsumura, Takuro and Nishida, Yasuharu and Uehira, Tomoko and Katano, Harutaka and Shirasaka, Takuma},
title = {Evaluation of human herpesvirus‐8 viremia and antibody positivity in patients with HIV infection with human herpesvirus‐8‐related diseases},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29324}
}
EUVIMED